Skip to main content
PROTIA INC. logo

PROTIA INC. — Investor Relations & Filings

Ticker · 303360 ISIN · KR7303360002 KO Manufacturing
Open in API
Filings indexed 246 across all filing types
Latest filing 2022-11-09 Report Publication Anno…
Country KR South Korea
Listing KO 303360

About PROTIA INC.

https://www.protia.co.kr/en/main

PROTIA INC. is an in-vitro diagnostics (IVD) company that develops, manufactures, and sells a wide range of diagnostic kits and instruments. The company is particularly known for its flagship product, PROTIA Allergy-Q, a multiplex allergy diagnostic kit for the quantitative determination of allergen-specific IgE. Its portfolio also includes point-of-care testing (POCT) solutions like the ImmuneCheck IgG kit, diagnostic tests for infectious and autoimmune diseases, cancer, and antibiotic susceptibility, as well as the ANITIA line for companion animal allergy testing. In addition to its product offerings, PROTIA provides comprehensive protein analysis services, including LC-MS/MS and characterization analysis, aiming to contribute to early disease prediction and diagnosis through innovative technology.

Recent filings

Filing Released Lang Actions
기업설명회(IR)개최
Report Publication Announcement Classification · 1% confidence The document is a formal announcement regarding an upcoming Investor Relations (IR) event (기업설명회). It provides details such as the date, location, target audience, and purpose of the meeting. Since it is an announcement of an event rather than the presentation materials themselves, and it fits the criteria for a regulatory announcement regarding corporate activities, it is classified as a Regulatory Filing (RNS).
2022-11-09 Korean
기타주요경영사항(자율공시)(코스닥시장 상장을 위한 상장예비심사 청구)
Regulatory Filings Classification · 1% confidence The document is a short regulatory announcement (590 characters) regarding the filing of a preliminary application for a KOSDAQ market listing. It is a corporate disclosure of a specific event (listing application) rather than a full financial report or a proxy statement. Since it is a regulatory announcement regarding a corporate action that does not fit into specific categories like M&A or share issuance, it falls under the general regulatory filing category.
2022-10-06 Korean
이전상장결정
Delisting Announcement Classification · 1% confidence The document is an official regulatory filing from ProteomeTech regarding a decision to transfer its stock listing to the KOSDAQ market. It details the reasons for the transfer, the timeline, board approval, and current share distribution. Since this is a specific regulatory announcement regarding corporate structure and listing status that does not fit into categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2022-10-04 Korean
기타주요경영사항(자율공시)(기술평가 결과)
Regulatory Filings Classification · 1% confidence The document is a regulatory filing from ProteomeTech regarding 'Other Major Management Matters' (자율공시), specifically disclosing the results of a technology evaluation (기술평가 결과) conducted by two agencies (NICE and KIPA) for the purpose of a KOSDAQ listing. Since this is a specific regulatory disclosure of material information that does not fit into financial reports, dividends, or management changes, it falls under the general regulatory filing category.
2022-08-31 Korean
조회공시요구(풍문또는보도)에대한답변(미확정)
Regulatory Filings Classification · 1% confidence The document is a formal response to a regulatory inquiry (조회공시) regarding market rumors about a KOSDAQ listing. It provides an update on the status of the company's listing application and technical evaluation. Since it is a regulatory disclosure regarding corporate developments that does not fit into specific categories like M&A or financial reports, it is classified as a Regulatory Filing (RNS).
2022-07-20 Korean
조회공시요구(풍문또는보도)에대한답변(미확정)
Regulatory Filings Classification · 1% confidence The document is a formal response to a 'Request for Disclosure' (조회공시 요구) from the Korea Exchange regarding rumors of a KOSDAQ listing. This is a standard regulatory disclosure process in the Korean market where companies must respond to market rumors or unusual stock activity. Since it does not fit into specific categories like M&A, financial reports, or director dealings, it falls under the general regulatory announcement category.
2022-06-20 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.